Literature DB >> 26984070

Meningococcemia in Adults: A Review of the Literature.

Shimon Takada1, Sho Fujiwara, Toshiya Inoue, Yuki Kataoka, Yoshiro Hadano, Kentaro Matsumoto, Kyoko Morino, Taro Shimizu.   

Abstract

We mainly refer to the acute setting of meningococcemia. Meningococcemia is an infection caused by Neisseria meningitidis, which has 13 clinically significant serogroups that are distinguishable by the structure of their capsular polysaccharides. N. meningitidis, also called meningococcus, is a Gram-negative, aerobic, diplococcus bacterium. The various consequences of severe meningococcal sepsis include hypotension, disseminated intravascular coagulation (DIC), multiple organ failure, and osteonecrosis due to DIC. The gold standard for the identification of meningococcal infection is the bacteriologic isolation of N. meningitidis from body fluids such as blood, cerebrospinal fluid (CSF), synovial fluid, and pleural fluid. Blood, CSF, and skin biopsy cultures are used for diagnosis. Meningococcal infection is a medical emergency that requires antibiotic therapy and intensive supportive care. Management of the systemic circulation, respiration, and intracranial pressure is vital for improving the prognosis, which has dramatically improved since the wide availability of antibiotics. This review of the literature provides an overview of current concepts on meningococcemia due to N. meningitidis infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26984070     DOI: 10.2169/internalmedicine.55.3272

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

Review 1.  Point-of-critical-care diagnostics for sepsis enabled by multiplexed micro and nanosensing technologies.

Authors:  Brandon K Ashley; Umer Hassan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-03-01

2.  Sepsis epidemiology and outcome in the paediatric intensive care unit of Vilnius University Children's Hospital.

Authors:  Odeta Bobelytė; Ieva Gailiūtė; Vytautas Zubka; Virginija Žilinskaitė
Journal:  Acta Med Litu       Date:  2017

3.  Fulminant meningococcemia.

Authors:  Diana Fidrocki; Larry Lutwick
Journal:  IDCases       Date:  2017-02-10

4.  Meningococcemia Masquerading as a Nonspecific Flu-Like Syndrome.

Authors:  Paula J Watts; Natasha Fazel; Dmitriy Scherbak
Journal:  Case Rep Crit Care       Date:  2018-11-05

5.  Symptomatic Vaginal Infection by Neisseria meningitidis Resulting in Meningitis with Septic Shock.

Authors:  Ryan Offman; Elissa Boggs; Adam Gwizdala
Journal:  Clin Pract Cases Emerg Med       Date:  2019-03-27

Review 6.  Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance.

Authors:  Bao Q Lam; Rashmi Srivastava; Jason Morvant; Sharmila Shankar; Rakesh K Srivastava
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

7.  Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.

Authors:  Júlia Coelho França Quintanilha; Marília Berlofa Visacri; Laís Sampaio Amaral; Carmen Silvia Passos Lima; Maria Letícia Cintra; Patricia Moriel
Journal:  BMC Cancer       Date:  2017-12-06       Impact factor: 4.430

Review 8.  Biological Functions of the Secretome of Neisseria meningitidis.

Authors:  Jan Tommassen; Jesús Arenas
Journal:  Front Cell Infect Microbiol       Date:  2017-06-16       Impact factor: 5.293

9.  First case report of fulminant septic shock from meningococcemia associated with Cryptococcus neoformans coinfection in an immunocompetent patient.

Authors:  Guilherme Dienstmann; Karina Tolfo Avi; Luiz Arthur Calheiros Leite; Joaquim Squizatto Alano; Matheus Leite Ramos de Souza; Marcelo da Silva Mulazani; Paula Cristina Gern Mendivil
Journal:  Med Mycol Case Rep       Date:  2019-10-03

Review 10.  Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease.

Authors:  Marco Vincenzo Lenti; Caterina Mengoli; Marta Vernero; Nicola Aronico; Laura Conti; Federica Borrelli de Andreis; Sara Cococcia; Antonio Di Sabatino
Journal:  Front Immunol       Date:  2020-03-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.